Attached files
| file | filename |
|---|---|
| EX-31 - CERTIFICATION - NewGen BioPharma Corp. | newg_ex31.htm |
| EX-10.2 - FORM OF WARRANT - NewGen BioPharma Corp. | newg_ex102.htm |
| EX-10.1 - FORM OF SECURITIES PURCHASE - NewGen BioPharma Corp. | newg_ex101.htm |
| 10-Q - FORM 10-Q - NewGen BioPharma Corp. | newg_10q.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of NewGen BioPharma Corp. (the “Company”) on Form 10-Q for the quarterly period ended January 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
|
|
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
|
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
|
Date: March 9, 2017 |
By: |
/s/ Bradford Long |
|
|
|
Name: |
Bradford Long |
|
|
|
Title: |
President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |
|